Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease

This study demonstrated significant longitudinal associations between multimodal core 1 AD biomarkers and cognitive function over 3 years in CU individuals, including those at the Aβ-negative stage. Distinct biomarker modalities provided complementary insights, emphasizing the potential of blood-based biomarkers for tracking subtle cognitive decline and neuroimaging for delineating vulnerable brain regions in aging and preclinical AD. These findings are crucial for identifying and monitoring high-risk CU individuals, further informing preventive intervention strategies for AD.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-10-17
DOI
https://doi.org/10.1212/wnl.0000000000214308
Citations
2
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease

Marta Milà‐Alomà, Gonzalo Sánchez‐Benavides, Kaj Blennow, Anna Brugulat‐Serrat et al.
2 citations
Neurology
Dementia and Cognitive Impairment Research
2.94
article

Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease

Marta Milà‐Alomà, Gonzalo Sánchez‐Benavides, Kaj Blennow, Anna Brugulat‐Serrat, Mahnaz Shekari, Gemma Salvadó, Juan Domingo Gispert, Oriol Grau‐Rivera, Henrik Zetterberg, Marc Suárez‐Calvet, Carolina Minguillón, David López‐Martos
article en
2 citations

Abstract

This study demonstrated significant longitudinal associations between multimodal core 1 AD biomarkers and cognitive function over 3 years in CU individuals, including those at the Aβ-negative stage. Distinct biomarker modalities provided complementary insights, emphasizing the potential of blood-based biomarkers for tracking subtle cognitive decline and neuroimaging for delineating vulnerable brain regions in aging and preclinical AD. These findings are crucial for identifying and monitoring high-risk CU individuals, further informing preventive intervention strategies for AD.

NeurologyVol. 105(9)
University of Science and Technology of China (CN), University of Wisconsin–Madison (US), University of California, San Francisco (US), Malmö University (SE), Lund University (SE), Sahlgrenska University Hospital (SE), Instituto de Salud Carlos III (ES), Sorbonne Université (FR), Pasqual Maragall Foundation (ES), Institut de Myologie (FR), Pitié-Salpêtrière Hospital (FR), UK Dementia Research Institute (GB), Hospital Del Mar (ES), Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (ES), Institut du Cerveau (FR), Global Brain Health Institute (US), Institute of Neurobiology (BG), Northern California Institute for Research and Education (US), University College London (GB), University of Gothenburg (SE)
Openalex Percentile: Top 8%
Dementia and Cognitive Impairment Research
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.